Latest news
Millennium entities (RVPH) disclose 1.07M-share, 8.2% Reviva Pharmaceuticals stake - Stock TitanStock Titan · Mon, 03 Aug 2026 21:47:47 GMTReviva Pharmaceuticals (RVPH) Soars 17.47% to $0.47, Testing Key Resistance Zone - Overnight Profile - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 01:46:48 GMTUBS Group (RVPH) exits Reviva Pharmaceuticals stake in updated report - Stock TitanStock Titan · Fri, 31 Jul 2026 20:46:52 GMTReviva Pharmaceuticals (NASDAQ:RVPH) plans second Phase 3 trial for brilaroxazine after FDA feedback, Nasdaq exit - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTReviva Pharmaceuticals (RVPH) Soars 17.47% to $0.47, Testing Key Resistance Zone - Percent Above MA - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 07:00:00 GMTReviva Pharmaceuticals (RVPH) Q1 2026 Earnings: Narrower Loss Surprises, Stock Dips on No Revenue Milestones - Share Repurchase Impact - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMTReviva Pharmaceuticals (RVPH) Q1 2026 Earnings: Narrower Loss Surprises, Stock Dips on No Revenue Milestones - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 06:40:37 GMTReviva Pharmaceuticals Holdings Inc. (RVPH) Faces Steep Decline, Approaches Critical Support at $0.40 - Ichimoku TK Cross - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 00:33:04 GMT